Home > Press > H&HGroup invests $2.8M in Evolved Nanomaterial Sciences
Harris & Harris Group invests $2,800,000 in Evolved Nanomaterial Sciences, Inc.
Posted on March 09, 2006
Harris & Harris Group, Inc., announced today that it led a
$3,300,000 Series A round of financing of privately held Evolved
Nanomaterial Sciences, Inc. (ENS) of Cambridge, MA. Harris &
Harris Group invested $2,800,000 in this round of financing.
ENS has developed a number of nanotechnology-enhanced approaches for
the resolution of chiral molecules. ENS is using its proprietary
ESPTM technology to manufacture high-capacity, high-generality HPLC
columns that simplify chiral method development and chiral
chromatography and purification. The A round funding will be used
to fill out its manufacturing and product development capabilities
and to support the launch of its first line of commercially
Harris & Harris Group is a publicly traded venture capital company
that now makes initial investments exclusively in tiny technology,
including nanotechnology, microsystems and microelectromechanical
systems (MEMS). The Company's last 27 initial private equity
investments have been in tiny technology-enabled companies. The
Company has 20,756,345 common shares outstanding.
Detailed information about Harris & Harris Group and its holdings
can be found on its website at www.TinyTechVC.com.
Copyright © Harris & Harris Group
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014